Trial Profile
A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2015
Price :
$35
*
At a glance
- Drugs Dapsone (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Allergan
- 12 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 15 Jan 2014 New trial record